Target intelligence / Profile preview

Ribosomal protein L7 pseudogene 40 (RPL7P40)

Target: RPL7P40
Molecular classification: Other, pseudogene (specifically a processed pseudogene derived from a ribosomal protein gene)

Overview

Ribosomal protein L7 pseudogene 40 (RPL7P40) is a processed pseudogene in the human genome. It arose via retrotransposition of the functional RPL7 gene, which encodes a component of the 60S large ribosomal subunit. Unlike the functional RPL7 gene, RPL7P40 does not encode a functional protein and is not involved in ribosome structure or protein synthesis. It is one of many processed pseudogenes of ribosomal protein genes scattered throughout the genome, reflecting past gene duplication and retrotransposition events[1][2][5][8].

Other names: RPL7_19_1215RPL7P40

Mechanism of action

None applicable (as it is not a drug target or functional gene)

Beyond the preview

Go deeper on Ribosomal protein L7 pseudogene 40 (RPL7P40).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L7 pseudogene 40 (RPL7P40).

Explore the full profile